Literature DB >> 19265820

NO may prompt calcium leakage in dystrophic muscle.

James G Tidball, S Armando Villalta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19265820     DOI： 10.1038/nm0309-243

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

1.  Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B.

Authors:  R W Ganster; B S Taylor; L Shao; D A Geller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.

Authors:  Sonia Messina; Alessandra Bitto; M'hammed Aguennouz; Letteria Minutoli; Maria C Monici; Domenica Altavilla; Francesco Squadrito; Giuseppe Vita
Journal:  Exp Neurol       Date:  2006-01-10       Impact factor: 5.330

Review 3.  Genomic and nongenomic effects of glucocorticoids.

Authors:  Cindy Stahn; Frank Buttgereit
Journal:  Nat Clin Pract Rheumatol       Date:  2008-09-02

4.  Effects of stretch-activated channel blockers on [Ca2+]i and muscle damage in the mdx mouse.

Authors:  Ella W Yeung; Nicholas P Whitehead; Thomas M Suchyna; Philip A Gottlieb; Frederick Sachs; David G Allen
Journal:  J Physiol       Date:  2004-11-04       Impact factor: 5.182

5.  Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy.

Authors:  S Armando Villalta; Hal X Nguyen; Bo Deng; Tomomi Gotoh; James G Tidball
Journal:  Hum Mol Genet       Date:  2008-11-07       Impact factor: 6.150

6.  Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment.

Authors:  Hannah G Radley; Marilyn J Davies; Miranda D Grounds
Journal:  Neuromuscul Disord       Date:  2008-01-22       Impact factor: 4.296

7.  Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle.

Authors:  Andrew M Bellinger; Steven Reiken; Christian Carlson; Marco Mongillo; Xiaoping Liu; Lisa Rothman; Stefan Matecki; Alain Lacampagne; Andrew R Marks
Journal:  Nat Med       Date:  2009-02-08       Impact factor: 53.440

8.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction.

Authors:  B J Petrof; J B Shrager; H H Stedman; A M Kelly; H L Sweeney
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice.

Authors:  M Wehling; M J Spencer; J G Tidball
Journal:  J Cell Biol       Date:  2001-10-01       Impact factor: 10.539

10.  Increased calcium influx in dystrophic muscle.

Authors:  P R Turner; P Y Fong; W F Denetclaw; R A Steinhardt
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539
View more
  4 in total

Review 1.  Treatment of dystrophin cardiomyopathies.

Authors:  Josef Finsterer; Linda Cripe
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

Review 2.  Physiology and pathophysiology of excitation-contraction coupling: the functional role of ryanodine receptor.

Authors:  Gaetano Santulli; Daniel R Lewis; Andrew R Marks
Journal:  J Muscle Res Cell Motil       Date:  2017-06-26       Impact factor: 2.698

3.  The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients.

Authors:  Ola Hammarsten; Pontus Ljungqvist; Björn Redfors; Mathias Wernbom; Hannes Widing; Bertil Lindahl; Sabin Salahuddin; Ruwayda Sammantar; Sandeep Jha; Annica Ravn-Fischer; Magnus Brink; Magnus Gisslen
Journal:  Clin Chim Acta       Date:  2022-01-05       Impact factor: 3.786

4.  CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotype.

Authors:  José-Manuel Cancela; Sabine de la Porte; Antoine de Zélicourt; Abdallah Fayssoil; Mbarka Dakouane-Giudicelli; Isley De Jesus; Ahmed Karoui; Faouzi Zarrouki; Florence Lefebvre; Arnaud Mansart; Jean-Marie Launay; Jerome Piquereau; Mariana G Tarragó; Marcel Bonay; Anne Forand; Sophie Moog; France Piétri-Rouxel; Elise Brisebard; Claudia C S Chini; Sonu Kashyap; Matthew J Fogarty; Gary C Sieck; Mathias Mericskay; Eduardo N Chini; Ana Maria Gomez
Journal:  EMBO Mol Med       Date:  2022-03-17       Impact factor: 14.260
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.